 |
bi-shRNAfurin and granulocyte macrophage colony stimulating factor augmented autologus tumor cell vaccine |
|---|---|
| Trade Name | |
| Orphan Indication | Ovarian cancer |
| USA Market Approval | USA |
| USA Designation Date | 2011-04-18 00:00:00 |
| Sponsor | Gradalis, Inc.;2545 Golden Bear Drive;Carrollton, Texas, 75006 |
